1. Introduction {#sec1}
===============

Hepatocellular carcinoma (HCC) ranks fifth among the world\'s most common malignancies and it is also the third most common cause of cancer-related death worldwide [@bib1]. Overall, HCC is newly developed in approximately 1,000,000 patients every year, and 600,000/yr people die of it [@bib2]. The incidence of HCC has rapidly risen due to increasing numbers of patients who are infected with hepatitis C, abuse alcohol, or have nonalcoholic steatohepatitis [@bib3], [@bib4]. With regards to the treatment of HCC, various medical modalities, such as the transcatheter hepatic artery chemo embolization and radiofrequency ablation, have been developed as palliative care methods, providing clinical efficacy and relative convenience for patients, particularly for those with localized HCC [@bib5].

Meanwhile, radiotherapy plays an important role in efficiently treating locally advanced HCC or a metastasized tumor from other organs [@bib6]. Radiotherapy is used in treatment when access to the above modalities is impossible, especially at the late stages of HCC [@bib7]. Moreover, the liver is a common target organ into which other cancers from extrahepatic sites metastasize most frequently; e.g., 10--25% of patients have surgery for primary colorectal cancer due to liver metastasis [@bib8]. Radiotherapy is also one of main medical modalities used to manage cholangiocarcinoma, another form of liver tumor, especially when it is in an unresectable state [@bib9]. In the above situations, radiation-induced liver injury (RILI) of the normal tissue is a critical factor limiting the application of radiotherapy [@bib10]. It is known that an approximately 5% risk of RILI occurs when radiation is applied to the entire liver tissue in a 30-Gy dose, the minimally effective clinical dose. However, the risk rates rapidly rise more than approximately 50% by 40 Gy. When patients were exposed to 60 Gy of radiation, the most effective dose for killing HCC, approximately 76% of them died of hepatic failure rapidly after the onset of radiation. In addition, liver tissue is the most vulnerable to radiation [@bib11], and has a high chance of being exposed to radiation during radiotherapy for cancers of other sites, especially of the upper abdomen or whole abdomen regions [@bib12].

The high energy from radiation generates free radicals such as hydroxyl radicals and aqueous electrons through the interaction of ionizing radiation with intracellular water molecules, which leads to cellular damage [@bib13]. Some agents show protective effects against the radiotherapy-induced tissue injury in both animal-based experiments and clinical trials. Amifostine (WR-2721) is well known as a free radical scavenger, which protects tissues from radiotherapy-related side effects, especially radio-pneumonitis [@bib14]. However, this agent shows toxicity at the optimal doses of radioprotection, and accompanies a relatively high expense and discomfort of intravenous administration before fractionized radiotherapy [@bib15]. Thus, it is critical issue to develop a radioprotective agent with high efficacy and low toxicity. Therefore, plant-derived phytochemicals or natural products have been adapted as candidates by many investigators.

*Panax ginseng* Meyer, also called Korean ginseng, has been used as a tonic or herbal medicine for thousands of years, particularly in East Asia. *P. ginseng* shows pharmaceutical effects on various diseases including type II diabetes mellitus, cardiovascular disorders, and chronic fatigue disorders in traditional usages as well as in current clinical studies [@bib16]. *P. ginseng* has also ameliorated the side effects of gastrointestinal troubles and pneumonitis by X-ray irradiation (IR) in animal-based experimental models [@bib17], [@bib18]. In terms of safety, *P. ginseng* is verified [@bib19]; therefore, it is now used as a functional food worldwide.

In the present study, we aimed to investigate protective effects of *P. ginseng* against RILI liver injury and its corresponding mechanisms using a mouse model exposed to a high dose of X-ray IR.

2. Materials and methods {#sec2}
========================

2.1. Preparation of *P. ginseng* extract and fingerprinting analysis {#sec2.1}
--------------------------------------------------------------------

*P. ginseng* root was obtained from Ginseng Nonghyup (Keum-san, South Korea). Sliced ginseng roots (1.2 kg) were boiled in 6.5 L of water for 100 min at 100°C using a high-speed automatic pressure earthen pot (Kyung-Hee Co-operation, Seoul, South Korea), and the extraction procedure was then repeated with 4.5 L of water. The *P. ginseng* extract (PGE) was then centrifuged for 30 min at 1,500 rpm, and the supernatant was lyophilized using a vacuum-freeze-drying system and stored at −20°C. The extraction yield was 7.1%.

A limulus amebocytelysate assay was performed to determine the endotoxin levels. The amounts of protopanaxadiol and proto panaxatriol ginsenosides in the PGE were estimated using an Alliance HPLC system (Waters, Milford, MA, USA). Three protopanaxadiol ginsenosides (Rb1, Rc, and Rd,) and three protopanaxatriol ginsenosides (Re, Rg1, and Rg2) were used as reference compounds. Standards for ginsenosides Rg3 and Re were purchased from Wako Chemical Co. (Tokyo, Japan) and Santa Cruz Biotechnology Inc. (Dallas, TX, USA), respectively, whereas the other ginsenosides were purchased from Sigma-Aldrich Co. (St. Louis, MO, USA). For chemical analysis, all standards were of HPLC grade. One gram of PGE and the six ginsenoside mixtures were dissolved in distilled water and subjected to HPLC. For the quantitative analysis of the PGE, each ginsenoside solution was prepared as six serially diluted concentrations.

All of the calibration curves were attained by assessing the peak areas in the range of 0.25--20 mg/L for all of the standard samples. The column was eluted with solvents A (18% acetonitrile) and B (80% acetonitrile) at a flow rate of 2.5 mL/min. The following solutions were used: 100% A and 0% B changed over 32 min, 80% A and 20% B to 80 min, 0% A and 100% B to 100 min, and 100% A and 0% B to 110 min. The detection wavelength was set to 230 nm. [Figs. 1](#fig1){ref-type="fig"}A and 1B showed that a total of six different ginsenosides were detected in PGE by HPLC analysis. Regarding the quantitative analysis, ginsenoside contents were shown in the range of 0.15 μg/mg to 3.76 μg/mg. Protopanaxadiol ginsenosides Rb1 and Rg3 were similar and were also the most abundant components (3.76 ± 0.02 μg/mg and 3.75 ± 0.05 μg/mg in PGE, respectively; [Fig. 1](#fig1){ref-type="fig"}C). The ginsenosides Re, Rc, Rg2, and Rd were present at the concentrations of 0.95 ± 0.01 μg/mg, 0.79 ± 0.12 μg/mg, 0.44 ± 0.06 μg/mg, 0.15 ± 0.01 μg/mg, respectively.

2.2. Animals and experimental design {#sec2.2}
------------------------------------

A total of 48 heads of specific pathogen-free female C57BL/6N mice (8-wk-old, 19--21 g) were obtained from a commercial animal breeder (Daehanbio-link, Chung-buk, South Korea), and acclimated for l wk before the experiment. All of the animals were housed in an environmentally controlled room at 22 ± 2°C and 60 ± 5% relative humidity under 12/12 h light/dark cycle. All of the mice were freely fed commercial pellets (G-Bio, Gyeong-gi, South Korea) and tap water *ad libitum*. The mice were randomly divided into six groups (*n* = 8 for each group): normal (distilled water without radiation), IR only (distilled water with radiation), PGE treatment groups (25 mg/kg, 50 mg/kg, or 100 mg/kg of PGE with radiation), and the positive control group (20 mg/kg of mealtonin with radiation). The distilled water or PGE was orally administered and melatonin was intraperitoneally injected for 4 consecutive d. All of the mice were anesthetized using a ketamine injection (100 mg/kg, intraperitoneally; Yuhan Pharmacy, Gyeong-gi-do, South Korea) and the upper abdomen including the liver of the mice were exposed to a single X-ray radiation dose of 15 Gy at a dose rate of 3 Gy/min using a linear accelerator (Siemens Medical Solutions, Erlangen, Germany), with shielding for the other parts of the mice. The last drug treatment was administered 1 h before X-ray exposure. All of the mice were sacrificed after 10 d of IR under ether anesthesia conditions. The whole blood was isolated via an abdominal vein, the liver tissue was removed and immediately weighed, and was fixed or stored in 10% neutral buffered formalin, RNAlater (Ambion, Austin, TX, USA), or in a deep freezer (−70°C) for histopathological analysis, mRNA expression analysis, and the determination of biochemical parameters, respectively.

Animal experiments were conducted in accordance with the Guide for the Care and Use of Laboratory Animals published by the United States National Institutes of Health. The protocol was approved by the Institutional Animal Care and Use Committee of Daejeon University (approval number DJUARB: DJUARB-2014-004).

2.3. Analysis of hematology and serum levels of liver enzymes {#sec2.3}
-------------------------------------------------------------

Peripheral blood was isolated from the abdomen via a 12-h fast vein and then collected from the venous plexus with an EDTA-coated capillary tube. The red blood cells, hemoglobin, white blood cells (WBC), and platelets in each sample were measured by a Hemavet 850 automatic analyzer (CDC Technologies, CT, USA). Serum was separated by centrifugation (3,000*g*, 15 min) following blood clotting. The serum levels of aspartatetransaminase (AST), alaninetransaminase (ALT), and alkalinephosphatase (ALP) were determined using an auto chemistry analyzer (Chiron, Emeryville, CA, USA).

2.4. Preparation of hepatic tissue homogenate and determination of protein concentration {#sec2.4}
----------------------------------------------------------------------------------------

For analysis of protein-based parameters, the isolated liver tissues were homogenized in a radioimmunoprecipitation assay buffer and centrifuged at 10,000*g* for 15 min, and protein content was determined using a Bicinchoninic Acid protein assay kit (Sigma, St. Louis, MO, USA). The supernatant was transferred and stored at −70°C until required.

2.5. Histopathological and immunohistochemical examination {#sec2.5}
----------------------------------------------------------

The hepatic tissues were fixed in 10% neutral buffered formalin and then embedded in paraffin and cut into 5-μm thick sections for histomorphological and immunohistochemical examination. Hepatic tissue section slides were stained with hematoxylin and eosin (H&E) according to standard procedures. For immunohistochemistry, sections were incubated with 4-hydroxynonenal (4-HNE) primary antibody (1:200; Abcam, Cambridge, UK) and biotinylated secondary antibody (Nichirei Biosciences, Tokyo, Japan), followed by the avidin--biotin--peroxidase complex. The immune-reactive signal was induced by their substrates, 3,3′-diaminobenzidine (Abcam) and 3-amino-9-ethylcarbazole (Abcam). The slides were counterstained with Mayer\'s hematoxylin and examined under an optical microscope (Leica Microsystems, Wetzlar, Germany).

2.6. Determination of lipid peroxidation in hepatic tissue {#sec2.6}
----------------------------------------------------------

Lipid peroxidation levels were evaluated by measuring methylenedioxyamphetamine (MDA) content using the thiobarbituric acid reactive substances method, as described previously [@bib20]. The absorbance of the supernatant was measured at 535 nm and 520 nm, and compared with a standard value (freshly prepared triethyl phosphate solution).

2.7. Determination of total reactive oxygen species in the hepatic tissue {#sec2.7}
-------------------------------------------------------------------------

Total reactive oxygen species (ROS) assay was performed using a previous method with slight modifications [@bib21]. The measurement of total ROS was measured using a microplate reader at 505 nm and 37°C (Molecular Device Corp., Sunnyvale, CA, USA). The ROS 1 unit was equal to 1 μg/mL H~2~O~2~. Serum nitric oxide levels were determined with the Griess method using Griess\' reagent \[1% sulfanilamide, 0.1% N-(1-naphthyl) ethylenediamine hydrochloride, and 2.5% H~3~PO~4~\].

2.8. Determination of total antioxidant capacity in hepatic tissue {#sec2.8}
------------------------------------------------------------------

The total antioxidant capacity (TAC) was determined using a using myoglobin solution with 2,2′-azino-bis [@bib22]. After reacting with the myoglobin/2,2′-azino-bis solution and samples, 2.5mM H~2~O~2~ was added. The absorbance of TAC was measured at 600 nm using a spectrophotometer 5 min after adding H~2~O~2~. TAC was expressed as the Trolox equivalents antioxidant capacity.

2.9. Determination of glutathione, glutathione-peroxidase, and glutathione-reductase in hepatic tissue {#sec2.9}
------------------------------------------------------------------------------------------------------

Total glutathione (GSH) content was determined by 5,5′-dithiobis-(2-nitrobenzoic acid) yielding a yellow chromospheres assay and absorbance at 412 nm was measured using a spectrophotometer [@bib23]. GSH levels were determined from a standard curve using reduced GSH and expressed as μM/mg protein.

The activity of GSH-peroxidase was calculated using a previous method with a slight modification [@bib24] using nicotinamide adenine dinucleotide phosphate (NADPH) reagent \[5mM NADPH, 42mM GSH, 10 units/mL GSH reductase (GSH-Rd) in 1.25 mL of distilled water\] with *tert*-butyl hydroperoxide solution which measured at 340 nm using a UV-visible spectrophotometer (Varian, Agilent Technologies, Santa Clara, CA, USA). Enzyme activity was represented according to the following formula: U/mL = (ΔA340 × dilution factor)/(6.22 × sample volume in mL). GSH-Rd activity was determined using 5,5′-dithiobis-(2-nitrobenzoic acid) with NADPH oxidation and reduction power [@bib25].

2.10. Determination of superoxide dismutase and catalase activity in hepatic tissue {#sec2.10}
-----------------------------------------------------------------------------------

Superoxide dismutase (SOD) activity in hepatic tissue was determined using a SOD assay kit (Dojindo Laboratories, Kumamoto, Japan) according to the manufacturer\' protocol. Bovine erythrocyte SOD (Sigma) was used a standard. 20 μL of standard or diluted hepatic tissue homogenate were mixed with 200 μL of WST-1 working solution in a 96-well plate. Subsequently, 20 μL of enzyme working solution were added to each well and thoroughly mixed. The plate was incubated at 37°C for 20 min, and was measured at 450 nm using a microplate reader (Molecular Device Corp., Sunnyvale, CA, USA).

Catalase activity in the hepatic tissue was determined according to the previous method [@bib26]. The protein sample reacted with hydrogen and Purpald solution (22.8mM of Purpald in 2N potassium hydroxide). The absorbance at 550 nm of the purple formaldehyde adduct was measured using a spectrophotometer.

2.11. Determination of tumor necrosis factor-α and interleukin-6 levels in hepatic tissue {#sec2.11}
-----------------------------------------------------------------------------------------

Hepatic protein levels of tumor necrosis factor-α (TNF-α) and interleukin-6 (IL-6) were measured using commercial enzyme-linked immunosorbent assay kits according to the manufacturers\' instructions (Biosource, Camarillo, CA, USA). The absorbance at 450 nm and 570 nm was measured using a spectrophotometer (Molecular Device Corp.).

2.12. Quantification of apoptotic hepatocytes in hepatic tissue {#sec2.12}
---------------------------------------------------------------

The terminal deoxynucleotidyl transferase 2′-deoxyuridine 5′-triphosphate nick-end labeling assay (TUNEL) assay was performed to detect apoptotic cells in hepatic tissues using a DeadEnd Fluorometric TUNEL System (Promega, Madison, WI, USA). Briefly, hepatic tissues were fixed in 10% formalin and embedded with paraffin. After deparaffinization and washing, the tissue specimens were incubated with proteinase K at room temperature for 10 min. Then, the sections were fixed in phosphate-buffered saline based 4% methanol-free formaldehyde solution. After several washes, the specimens were incubated with terminal deoxynucleotidyl transferase, recombinant enzyme at 37°C for 60 min in the humidified chamber by avoiding direct light. Tissue sections were immersed in the saline-sodium citrate solution for 15 min at room temperature after incubation, and washed several times for completing removals of unincorporated fluorescein-12-2′-deoxyuridine 5′-triphosphate. After that, the apoptotic cells were immediately analyzed under a fluorescence microscope using a standard fluoresce in filter set to view the green fluorescence at 520 ± 20 nm (100× magnification; Olympus, Center Valley, PA, USA). The number of TUNEL-positive cells was counted from five randomly selected fields at 100× magnification per liver sample. Results were expressed as the mean number of TUNEL-positive apoptotic hepatocytes per microscopic field.

2.13. Gene expression analysis by quantitative real-time polymerase chain reaction {#sec2.13}
----------------------------------------------------------------------------------

Total RNA was extracted from hepatic tissue samples with Trizol reagent (Molecular Research Center, Cincinnati, OH, USA). The cDNA was synthesized from total RNA (2 μg) in a 20-μL reaction using a High-Capacity cDNA reverse transcription kit (Ambion). The primers for *Bax*, *Bcl-2*, and *Bcl-xL*, and *β-actin* were as follows (forward and reverse) for *Bax*: AGA CAC CTG AGC TGA CCT TGG A and GAG ACA CTC GCT CAG CTT G; for *Bcl-2* GGG ATG CCT TTG TGG AAC TAT ATG and CTG AGC AGG GTC TTC AGA GAC A; for *Bcl-xL*: ACC GCA GAG CGT TCA GTG AT and CCA TCC CGA AAG AGT TCA TTC A; and for *β-actin*: CGT GCG TGA CAT CAA AGA GAA and ACC GCT CGT TGC CAA TAG TG, respectively. Results were normalized using *β-actin* as the reference gene, and are represented as percentages versus the reference gene. Real-time polymerase chain reaction (PCR) reactions were conducted using PikoReal Real-Time PCR System (Thermo Scientific, San Jose, CA, USA) and performed according to the manufacturer\'s protocol. Reactions were performed in a total volume of 10 μL, containing 1.5 μL of cDNA, 5 μL of SYBR Green qPCR Master Mix (K0259, Thermo Scientific, San Jose, CA, USA), 0.5 μL of each primer, and 3 μL of water (R0581, Thermo Scientific).PCR amplification cycles were carried out as follows: 30 s at 98°C, 40 cycles of 5 s at 98°C, 10 s at 65°C, and 30 s at 72°C. For each sample, two reactions were performed at the same time. One reaction was performed to determine the mRNA level of the target gene, and the second was performed to determine level of *β-actin*.

2.14. Western blotting analysis {#sec2.14}
-------------------------------

Whole liver homogenates were prepared from liver samples according to the previously described [@bib27]. Protein extracts from the hepatic tissues (40 μg for each) were resolved in the sodium dodecyl sulfate-polyacrylamide gel electrophoresis. After blocking membrane, immunoblotting was performed based on the manufacturer\'s instruction for each primary antibody against *p53*, *Bax*, *Bcl-2*, and *Bcl-xL* (all of primary antibodies were purchased from the Thermo Scientific Co.). Membranes were then incubated with the secondary antibodies against rabbit or mouse (Santa Cruz Biotechnology, Inc., CA, USA). Anti-β-actin antibody (Thermo Scientific Co.) was used as the internal control for equal loading of proteins

2.15. Statistical analysis {#sec2.15}
--------------------------

All data are expressed as means ± standard deviations. The statistical significance differences between the groups were evaluated by one-way analysis of variance followed by *post-hoc* multiple comparisons with Fisher\'s Least Significant Difference *t*-test using the IBM SPSS statistics software, version 20.0 (SPSS Inc., Chicago, IL, USA). Differences at *p* \< 0.05, *p* \< 0.01, or *p* \< 0.001 were considered statistically significant.

3. Results {#sec3}
==========

3.1. Effects of PGE on the body weights, liver weights, and hematotoxicity {#sec3.1}
--------------------------------------------------------------------------

The final body weight was 20.9 ± 0.2 g in the normal group, whereas the IR-only group was significantly decreased as compared with the normal group (17.0 ± 1.4 g, *p* \< 0.01). Pretreatment with PGE slightly recovered body weight loss without significance ([Table 1](#tbl1){ref-type="table"}). Both the absolute and relative liver mass was significantly reduced by IR and pretreatment with PGE did not affect them ([Table 1](#tbl1){ref-type="table"}).

IR drastically decreased the hemoglobin concentration, and number of red blood cells, WBCs (most drastically), and platelets in peripheral blood of mice. The pretreatment with PGE showed a slight protective pattern especially on WBC counts, without statistical significance (*p* = 0.07 for 100 mg/kg). The PGE significantly decreased platelet counts (*p \<* 0.05 for 25 mg/kg and 50 mg/kg), in a dose-reverse manner. Melatonin significantly increased platelet counts, but other parameters were not affected ([Table 1](#tbl1){ref-type="table"}).

3.2. Effects of PGE on the histopathological analysis {#sec3.2}
-----------------------------------------------------

IR caused a steatotic alteration evidenced by measuring H&E staining, whereas pretreatment with PGE remarkably attenuated these histopathological alterations ([Fig. 2](#fig2){ref-type="fig"}A). The 4-HNE signal, which is a potent marker of lipid peroxidation, was strongly enhanced in the IR-only group, but PGE groups showed the reduction of 4-HNE signals (part of the dark brown color in [Fig. 2](#fig2){ref-type="fig"}B). Those changes were also attenuated by pretreatment with melatonin.

3.3. Effects of PGE on the IR-induced total ROS level, MDA content, and triglyceride levels in hepatic tissue {#sec3.3}
-------------------------------------------------------------------------------------------------------------

Total ROS level was significantly higher by approximately 1.3-fold than that of the normal group, which is significantly attenuated by pretreatment with PGE (especially 100 mg/kg; [Fig. 2](#fig2){ref-type="fig"}C). The hepatic MDA contents in the IR-only group was significantly increased by 2.4-fold compared with the normal group, while pretreatment with PGE significantly ameliorated MDA levels as compared with the IR-only group (*p \<* 0.01 for 50 mg/kg and 100 mg/kg; [Fig. 2](#fig2){ref-type="fig"}D). Hepatic triglyceride levels were also markedly increased by about 1.3-fold in the IR-only group compared with the normal group, whereas PGE pretreatment significantly attenuated it (*p \<* 0.05 for 50 mg/kg and *p* \< 0.01 for 100 mg/kg, respectively; [Fig. 2](#fig2){ref-type="fig"}E).

The melatonin showed similar effects on the hepatic MDA and triglyceride levels, but not total ROS levels.

3.4. Effects of PGE on the IR-induced nonenzymatic antioxidant component alterations in hepatic tissue levels {#sec3.4}
-------------------------------------------------------------------------------------------------------------

IR significantly decreased hepatic tissue levels of TAC by approximately 0.8-fold as compared with the normal group, while pretreatment with PGE significantly increased it compared with the control group (*p* \< 0.05 for 25 mg/kg, 50 mg/kg, and 100 mg/kg, respectively; [Table 1](#tbl1){ref-type="table"}). The total GSH contents in the IR-only group were considerably depleted by 0.5-fold as compared with the normal group, whereas pretreatment with PGE significantly blocked the deterioration as compared with the IR-only group (*p* \< 0.05 for 100 mg/kg and *p* \< 0.01 for 50 mg/kg, respectively; [Table 1](#tbl1){ref-type="table"}).

Pretreatment with melatonin also positively affected TAC and total GSH contents in hepatic tissue.

3.5. Effect of PGE on the IR-induced enzymatic antioxidant components alterations in hepatic tissue levels {#sec3.5}
----------------------------------------------------------------------------------------------------------

15-Gy X-ray IR considerably depleted GSH-Rd, SOD, and catalase activities in hepatic tissues compared with the normal group by approximately 0.8-, 0.3-, and 0.6-fold respectively, whereas pretreatment significantly prevented those deteriorations (GSH-Rd: *p* \< 0.05 for 25 mg/kg, *p* \< 0.001 for 50 mg/kg and 100 mg/kg; SOD: *p* \< 0.05 for 50 mg/kg and 100 mg/kg; catalase: *p* \< 0.05 for 50 mg/kg and 100 mg/kg, *p* \< 0.01 for 25 mg/kg, respectively; [Table 1](#tbl1){ref-type="table"}). The GSH-peroxidase activity was lowered by 0.5-fold in the normal group, and the pretreatment with PGE slightly increased it without significance ([Table 1](#tbl1){ref-type="table"}).

Melatonin showed a significant increase of GSH-Rd activities, but not in the others in hepatic tissue.

3.6. Effect of PGE on the IR-induced serum levels of liver enzymes and hepatic protein levels of pro-inflammatory cytokines {#sec3.6}
---------------------------------------------------------------------------------------------------------------------------

15-Gy X-ray IR markedly increased serum levels of AST, ALT, and ALP by approximately 3.2-, 2.1-, and 1.5-fold as compared with the normal group, respectively. Pretreatment with PGE (especially 100 mg/kg) significantly decreased serum levels of ALT and ALP as compared with the IR-only group, but not AST levels (*p* \< 0.05 in ALT and ALP, respectively; [Fig. 3](#fig3){ref-type="fig"}A).

Protein levels of pro-inflammatory cytokines, such as TNF-α and IL-6, were increased by 2.4- and 1.2-fold in the IR group compared with the normal group, but PGE significantly ameliorated these elevations (*p* \< 0.05 for 50 mg/kg and 100 mg/kg in TNF-α and 25 mg/kg, 50 mg/kg, and 100 mg/kg in IL-6, respectively; [Figs. 3](#fig3){ref-type="fig"}A and 3C).

Melatonin showed a similar effect on the serum levels of ALT and ALP, but not pro-inflammatory cytokines in hepatic tissue.

3.7. Effect of PGE on the IR-induced apoptosis signals in hepatic tissue levels {#sec3.7}
-------------------------------------------------------------------------------

Irradiation notably enhanced the apoptosis cells (stained in nuclei parts as a green fluorescence) by measuring TUNEL staining in the hepatic tissue, while pretreatment with PGE groups considerably reduced them compared with the IR-only group ([Figs. 4](#fig4){ref-type="fig"}A and 4B). In the western blot analysis, the proapoptotic proteins such as p53 and Bax were markedly increased, whereas antiapoptotic proteins including BcL-2 and BcL-xL were notably decreased by X-ray IR as compared with the normal groups. The above alterations were significantly normalized by pretreatment with PGE ([Figs. 5](#fig5){ref-type="fig"}A and 5B).The hepatic gene expression level of *Bax* was approximately 2.1-fold higher, whereas *Bcl-2* and *Bcl-xL* were about 0.7- and 0.8-fold lower than that of the normal group by IR, respectively. Pretreatment with PGE significantly normalized above abnormalities as compared with IR-only group (*p* \< 0.05 for 100 mg/kg in *Bcl-2* and *Bcl-xL*, *p* \< 0.01 for 50 mg/kg in *Bcl-xL*, and 100 mg/kg in *Bax*, respectively; [Fig. 5](#fig5){ref-type="fig"}C).

Pretreatment with melatonin also notably improved the deteriorations of apoptosis signals in the hepatic tissue ([Figs. 5](#fig5){ref-type="fig"}A--5C).

4. Discussion {#sec4}
=============

We investigated the PGE\'s effects on RILI and its potential corresponding mechanisms. To produce the RILI mice model, we exposed mice to an X-ray at a single dose of 15 Gy, approximately equivalent to 60 Gy for humans, which is a 2-fold higher dose than that for clinical use, resulting in 5--50% higher probabilities for liver failure within 5 yr [@bib28]. Although we irradiated whole liver in a localized manner, IR-induced hematoxicity, including severe leucopenia and weight loss occurred besides liver injury ([Table 1](#tbl1){ref-type="table"}; [Fig. 2](#fig2){ref-type="fig"}, [Fig. 3](#fig3){ref-type="fig"}A). PGE pretreatment significantly protected the hepatic injury, as evidenced by normalization of ALT and ALP, but not AST ([Fig. 3](#fig3){ref-type="fig"}A). Some portions of AST might be released from not only liver but also heart or muscles, because it is known to be distributed in heart and muscle, unlike ALT and ALP [@bib29]. Additionally, IR markedly induced hepatic steatosis, as supported by histological findings and the increase of hepatic triglyceride levels; then, it was significantly ameliorated by PGE pretreatment ([Figs. 2](#fig2){ref-type="fig"}A and 2E). The steatotic alteration is a representative pathological feature of RILI [@bib30]. The radiation-induced thrombocytopenia was augmented in the PGE pretreated groups; however, it is not supposed to be associated with PGE because of its inversely dose-dependent manner ([Table 1](#tbl1){ref-type="table"}).

However, oxidative stress has been well known to be a major contributor to tissue damage and the following chronic inflammatory reaction under IR conditions [@bib31]. IR led to severe oxidative stress status, as demonstrated by the measurement of total ROS levels and MDA content in hepatic tissue. These results were well supported by immunohistochemistry against 4-HNE, a potent marker of lipid peroxidation ([Figs. 2](#fig2){ref-type="fig"}B--2D). High-energy X-ray directly generates ROS, which leads to damage of DNA, lipids, proteins, cells, and tissues [@bib32]. In the present study, pretreatment with PGE (especially 100 mg/kg) significantly ameliorated the liver tissue oxidation ([Figs. 2](#fig2){ref-type="fig"}B--2D). Most biological organics are known to have well evolved into antioxidant components against oxidative stressors, and the liver is a crucial organ for defense against oxidative stress [@bib33]. As we expected, the levels of most antioxidant components in the hepatic tissue were considerably depleted by IR, whereas those alterations were significantly restored by PGE pretreatment. High-energy IR initiates a sequence of events. The excessive generation of ROS in initial step leads to inflammatory reactions, which are then followed by chronic oxidative stress response [@bib34].

Under IR conditions, inflammatory cells, such as neutrophils and Kupffer cells, are recruited to the IR-derived inflamed lesion via release of pro-inflammatory cytokines [@bib35]. This status subsequently evokes the tissue damage via turning on the apoptosis signals [@bib36]. Therefore, we further explored that IR-induced hepatic apoptosis using a TUNEL assay. As expected, the apoptosis signals were markedly enhanced by IR ([Figs. 4](#fig4){ref-type="fig"}A and 4B). This finding coincided with the assessment of apoptotic signaling molecular proteins. Irradiation was known to causes apoptotic cellular damages via intrinsic pathway via the upregulation of the p53 protein, activating proapoptotic molecules including Bax but suppressing antiapoptotic molecules such as BcL-2 and BcL-xL, respectively [@bib37], [@bib38]. The IR-induced activation of apoptotic signals were significantly attenuated by PGE treatment in our western blot analysis ([Figs. 5](#fig5){ref-type="fig"}A and 5B). The analysis of mRNA gene expressions supported the above results ([Fig. 5](#fig5){ref-type="fig"}C), and these are supposed to be strongly linked to the modulation of pro-inflammatory cytokines, particularly TNF-α ([Figs. 3](#fig3){ref-type="fig"}B and 3C).

Moreover, our results showed a drastic depletion (one-third compared with the normal group) of SOD by IR, which transforms the superoxide (O~2~^•−^), a most violent radical molecule, into hydrogen peroxide, a relatively low aggressive radical [@bib39]. Regarding the IR conditions, the excessive generation of O~2~^•−^ molecules caused mitochondrial dysfunction that contributes to liver injury [@bib40]. Our study showed that the correlation between depletion of SOD activities and enhancement of apoptosis signals was due to radiation ([Fig. 4](#fig4){ref-type="fig"}, [Fig. 5](#fig5){ref-type="fig"}; [Table 1](#tbl1){ref-type="table"}).

Radiotherapy is an essential modality for treating cancers patients and it can help to increase survival rates [@bib41]. The reduction or prevention of the adverse effects, normal tissue damage, is a clinically critical issue during radiotherapy, including liver occupying cancers [@bib42]. Only one-third of patients with HCC or cholangiocarcinoma can possibly be treated with curative therapies. Moreover, the prevalence of the above cancers has been increasing every year, thus it is estimated that the demand for radiotherapy will be increased [@bib7]. To date, no therapeutic agent to prevent or reduce RILI exists. *P. ginseng* has been commonly used to treat a wide variety of diseases [@bib43]. Previous studies reported that *P. ginseng* beneficially affected side effects or adverse effects during the IRs [@bib44], [@bib45]; however, no study has been conducted regarding RILI.

In the current study, we found the protective effects of PGE against RILI primarily through antioxidant actions and modulation of apoptosis signals. There are a number of studies on antioxidant effects of *P. ginseng* in chemotherapy and IR animal models [@bib46], [@bib47], [@bib48]. Previous studies showed that the ginsenosides Rg1 and Rb1, major components of *P. ginseng*, ameliorated the apoptosis signals via modulation of the p53 protein in HaCaT cells under UV-IR conditions [@bib49]. In addition, the ginsenoside Rg1 also ameliorated caspase-3 activity in an isoflurane-induced apoptotic rat model [@bib50]. Quantitative analysis of PGE revealed that Rg1 and Rb1 are most abundant compounds in PGE ([Fig. 1](#fig1){ref-type="fig"}), and thus Rg1 and Rb1 would be thought of as active compounds in our experimental model. However, our previous study indicated that nonginsenoside fractions of *P. ginseng* also exerted protective effects, comparable with the ginsenoside fraction, on cisplatin-induced gastric damage in a rat model [@bib51], and others also showed similar effects using nonsaponin fractions [@bib52]. Moreover, the general formula of *P. ginseng* traditionally comprises the whole fraction, as the PGE used in our current study. From our data, 50 mg/kg and 100 mg/kg of PGE showed consistently positive effects, but 25 mg/kg of PGE did not. This means that the different effects occur in a dose-dependent manner, which must be considered in clinical studies or use.

The current study model has a limitation, which is dissimilar to clinical studies irradiating bodies under-containing tumor masses. Other studies have proven that *P. ginseng* or its derived compounds show dominant effects on the various cancers using *in-vivo* models [@bib53], [@bib54]. Additionally, one study found that IR and *P. ginseng* also synergistically recovered the survival rate of liver cancer [@bib55]. Thus our data provided the experimental evidence for the clinical relevance of *P. ginseng* as a potential herbal remedy.

Taken together, we proved the protective effects of *P. ginseng* on RILI through amelioration of oxidative stress as well as modulation of apoptosis signals. Our results indicate that *P. ginseng* could be applied for preventing RILI in radiation therapy.
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![Fingerprinting analysis of *Panax ginseng extract* (PGE) using HPLC. The PGE and its active compounds were subjected to HPLC. All chromatograms were obtained at a wavelength of 230 nm (details in the text). (A) Histogram of PGE. (B) Standard mixtures. (C) The quantitative analysis of reference compounds in PGE. HPLC, high performance liquid chromatography.](gr1){#fig1}

![Histopathological findings and total reactive oxygeb species (ROS), malondialdehyde (MDA), and triglyceride (TG) contents in hepatic tissues. (A) The representative photomicrographs of liver sections processed for hematoxylin and eosin staining was examined under the microscopy (100×). (B) The representative photomicrographs of liver sections processed for immunohistochemical staining for 4-hydroxynonenal was examined under the microscopy (100×). Hepatic tissue levels of total (C) ROS, (D) MDA, and (E) TG were determined in hepatic tissue. Data were expressed as the mean ± standard deviation (*n* = 8). \**p* \< 0.01 was compared with the normal group. \*\**p* \< 0.001 was compared with the normal group. \*\*\**p* \< 0.05 was compared with the IR-only group. \*\*\*\**p* \< 0.01 was compared with the IR-only group. \*\*\*\*\**p* \< 0.001 was compared with the IR-only group. IR, irradiation; Mel, melatonin.](gr2){#fig2}

![Serum biochemistries and pro-inflammatory cytokines in hepatic tissues. (A) Serum biochemistries including aspartatetransaminase (AST), alaninetransaminase (ALT), and alkalinephosphatase (ALP) were analyzed. (B) Hepatic tissue levels of tumor necrosis factor-α (TNF-α) and (C) interleukin-6 (IL-6) were determined using a commercial enzyme-linked immunosorbent assay kit. Data were expressed as the mean ± standard deviation (*n* = 8). \**p* \< 0.01 was compared with the normal group. **\*\****p* \< 0.001 was compared with the normal group. \*\*\**p* \< 0.05 was compared with the IR-only group. \*\*\*\**p* \< 0.01 was compared with the IR-only group. \*\*\*\*\**p* \< 0.001 was compared with the IR-only group. IR, irradiation; Mel, melatonin; PGE, *Panax ginseng* extract.](gr3){#fig3}

![Terminal deoxynucleotidyl transferase 2′-deoxyuridine 5′-triphosphate nick-end labeling assay (TUNEL) assay in hepatic tissue. (A) Apoptotic hepatocytes in hepatic tissue were identified by TUNEL assay and (B) the TUNEL-positive cells in hepatic tissues were quantified (100×). Data were expressed as the mean ± standard deviation (*n* = 8). \**p* \< 0.01 compared with the normal group. \*\**p* \< 0.01 compared with the IR-only group. IR, irradiation; Mel, melatonin; PGE, *Panax ginseng* extract.](gr4){#fig4}

![Assessments of cellular apoptosis in hepatic tissue. (A) The pro-and antiapoptosis related genes were measured by western blot analysis and (B) protein intensity was analyzed. (C) The mRNA expression levels of apoptosis related signals were measured by real-time polymerase chain reaction. The mRNA expression and protein levels were normalized to that of *β-actin*. Data were expressed as the mean ± standard deviation (*n* = 8). \**p* \< 0.01 was compared with the normal group. \*\**p* \< 0.001 was compared with the normal group. \*\*\**p* \< 0.05 was compared with the IR-only group. \*\*\*\**p* \< 0.01 was compared with the IR-only group. \*\*\*\*\**p* \< 0.001 was compared with the IR-only group. Bax, Bcl-2-associated X protein; BcL, B-cell lymphoma 2; BcL-xL, B-cell lymphoma-extra large; IR, irradiation; Mel, melatonin; PGE, *Panax ginseng* extract; p53, tumor protein 53.](gr5){#fig5}

###### 

Effects on body and liver weights, as well as antioxidant components

  Groups                                       Normal           IR only            IR with PGE treatment (mg/kg)   IR with Mel 20 (mg/kg)                                        
  -------------------------------------------- ---------------- ------------------ ------------------------------- ------------------------------ ------------------------------ ----------------------------
  Final body weight (g)                        20.9 ± 0.2       17.0 ± 1.4\*\*     17.7 ± 2.6                      18.0 ± 1.7                     18.0 ± 1.1                     16.0 ± 2.0
  Absolute liver mass (g)                      1.0 ± 0.1        1.2 ± 0.1\*        1.1 ± 0.2                       1.2 ± 0.1                      1.3 ± 0.1                      1.0 ± 0.2
  Relative liver mass (%)                      4.8 ± 0.4        6.8 ± 0.5\*\*\*    6.5 ± 0.1                       6.8 ± 0.1                      6.9 ± 0.1                      6.7 ± 0.1
  RBC (10^6^/μL)                               9.1 ± 0.2        7.1 ± 0.5\*\*      7.0 ± 0.4                       7.4 ± 0.8                      7.9 ± 0.5                      7.8 ± 0.7
  Hemoglobin (g/dL)                            15.5 ± 0.3       10.9 ± 0.8\*\*\*   11.0 ± 0.7                      10.1 ± 0.4                     9.1 ± 0.6                      9.5 ± 1.3
  WBC (k/uL)                                   5.7 ± 1.8        2.0 ± 0.3\*\*\*    1.7 ± 0.4                       2.6 ± 0.3                      3.5 ± 1.2                      3.3 ± 0.9
  Platelet counts (k/uL)                       1298.0 ± 221.2   1158.0 ± 57.3      880.2 ± 143.8**\*\*\*\***       1088.4 ± 43.9**\*\*\*\***      1012.4 ± 54.2                  1368.0 ± 174.2**\*\*\*\***
  Total antioxidant capacity (uM/mg protein)   125.7 ± 13.6     106.1 ± 12.9\*     193.5 ± 42.8**\*\*\*\***        170.3 ± 13.5**\*\*\*\*\*\***   173.9 ± 26.8**\*\*\*\*\*\***   187.1 ± 38.4**\*\*\*\*\***
  Total GSH contents (μM/mg protein)           169.3 ± 71.3     85.2 ± 26.2\*\*    152.3 ± 26.2                    138.9 ± 23.3**\*\*\*\*\***     112.2 ± 19.9**\*\*\*\***       110.0 ± 18.5**\***
  GSH-peroxidase activity (units/mg protein)   1.5 ± 2.1        0.7 ± 0.7          0.8 ± 0.5                       0.6 ± 0.4                      0.8 ± 0.8                      0.5 ± 0.2
  GSH-reductase activity (units/mg protein)    25.1 ± 2.7       21.2 ± 2.6\*       38.7 ± 8.6**\*\*\*\***          34.1 ± 2.7**\*\*\*\*\*\***     34.7 ± 5.4**\*\*\*\*\*\***     37.4 ± 7.7**\*\*\*\*\***
  Catalase activity (units/mg protein)         666.4 ± 134.5    422.6 ± 53.8\*\*   807.7 ± 130.1**\*\*\*\*\***     647.3 ± 196.3**\*\*\*\***      671.4 ± 162.7**\*\*\*\***      604.8 ± 411.0
  SOD activity (units/mg protein)              23.9 ± 6.5       7.8 ± 1.2\*\*\*    5.6 ± 2.3                       11.6 ± 3.6**\*\*\*\***         11.5 ± 3.6**\*\*\*\***         18.3 ± 20.9

Data are expressed as the mean ± standard deviation (*n* = 4--7)

\**p* \< 0.05 was compared with the normal group

\*\**p* \< 0.01 was compared with the normal group

\*\*\**p* \< 0.001 was compared with the normal group

\*\*\*\**p* \< 0.05 was compared with the IR-only group

\*\*\*\*\**p* \< 0.01 was compared with the IR-only group

\*\*\*\*\*\**p* \< 0.001 was compared with the IR-only group

GSH, glutathione; IR, irradiation; Mel, melatonin; PGE, *Panax ginseng* extract; RBC, red blood cells; SOD, superoxide dismutase; WBC, white blood cells
